George Magrath

Concepts (128)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Tomography, Optical Coherence
8
2017
88
1.270
Why?
Macular Edema
3
2022
21
1.190
Why?
Fluorescein Angiography
8
2017
57
1.170
Why?
Fovea Centralis
3
2017
11
0.880
Why?
Choroid Diseases
1
2022
6
0.860
Why?
Lymphoma
1
2022
116
0.810
Why?
Retinal Vessels
3
2017
74
0.740
Why?
Orbital Neoplasms
2
2014
21
0.600
Why?
Cataract Extraction
1
2018
127
0.560
Why?
Cataract
1
2018
134
0.550
Why?
Diabetes Complications
1
2018
249
0.540
Why?
Varicose Veins
1
2015
11
0.500
Why?
Orbit
1
2015
30
0.500
Why?
Retinoblastoma
3
2020
26
0.460
Why?
Esophageal Neoplasms
1
2014
150
0.450
Why?
Urinary Bladder Neoplasms
1
2014
138
0.450
Why?
Eye Diseases
1
2013
38
0.450
Why?
Optic Disk
1
2013
37
0.440
Why?
Optic Nerve
1
2013
55
0.440
Why?
Adenocarcinoma
1
2014
475
0.390
Why?
Fluconazole
1
2010
26
0.370
Why?
Antifungal Agents
1
2010
108
0.350
Why?
Choroid Neoplasms
2
2017
20
0.290
Why?
Capillaries
2
2017
105
0.280
Why?
Retinal Neoplasms
2
2017
22
0.280
Why?
Magnetic Resonance Imaging
1
2015
2223
0.270
Why?
Fundus Oculi
2
2017
33
0.240
Why?
Retina
2
2017
252
0.240
Why?
Humans
21
2022
68618
0.220
Why?
Melanoma
2
2017
335
0.220
Why?
Choroid
1
2022
22
0.210
Why?
Retinal Dystrophies
1
2022
4
0.210
Why?
Ophthalmic Solutions
1
2022
39
0.210
Why?
Retinitis Pigmentosa
1
2022
17
0.210
Why?
Integrins
1
2022
115
0.200
Why?
Glaucoma
2
2014
50
0.200
Why?
Diabetic Retinopathy
1
2022
110
0.200
Why?
Healthy Volunteers
2
2017
78
0.180
Why?
Male
13
2020
37321
0.180
Why?
Brachytherapy
2
2017
79
0.170
Why?
Equipment Design
2
2017
500
0.170
Why?
Retinal Diseases
2
2016
40
0.160
Why?
Antihypertensive Agents
2
2014
498
0.160
Why?
Uveal Neoplasms
1
2017
16
0.150
Why?
Optical Imaging
1
2017
46
0.140
Why?
Middle Aged
6
2017
21147
0.140
Why?
Intraocular Pressure
2
2014
143
0.140
Why?
Prospective Studies
3
2022
3705
0.140
Why?
Child, Preschool
4
2020
3187
0.130
Why?
Female
10
2020
38074
0.130
Why?
Radiation Injuries
1
2016
97
0.130
Why?
Xanthogranuloma, Juvenile
1
2015
4
0.130
Why?
Valsalva Maneuver
1
2015
10
0.130
Why?
Iris Diseases
1
2015
8
0.130
Why?
Hamartoma
1
2015
24
0.130
Why?
Incidental Findings
1
2015
42
0.120
Why?
Multimodal Imaging
1
2015
62
0.120
Why?
Diagnosis, Differential
2
2015
1140
0.120
Why?
Image Enhancement
1
2015
143
0.120
Why?
Accidents, Traffic
1
2015
109
0.120
Why?
Neoplasm Recurrence, Local
1
2017
446
0.120
Why?
Retinal Pigment Epithelium
1
2015
145
0.110
Why?
Actinomycetales Infections
1
2013
2
0.110
Why?
Orbital Cellulitis
1
2013
2
0.110
Why?
Arcanobacterium
1
2013
2
0.110
Why?
Retinal Artery Occlusion
1
2013
7
0.110
Why?
Eye Infections, Bacterial
1
2013
15
0.110
Why?
Rhabdomyosarcoma
1
2013
36
0.110
Why?
Diagnostic Imaging
1
2014
201
0.110
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2016
468
0.110
Why?
Biopsy
1
2014
540
0.110
Why?
Clinical Trials as Topic
2
2014
848
0.100
Why?
Palliative Care
1
2014
271
0.100
Why?
Reproducibility of Results
1
2017
2077
0.100
Why?
Coccidioidomycosis
1
2010
6
0.090
Why?
Voriconazole
1
2010
11
0.090
Why?
Retreatment
1
2010
59
0.090
Why?
Infant
4
2020
2891
0.090
Why?
Drug Evaluation, Preclinical
1
2010
137
0.090
Why?
Triazoles
1
2010
43
0.090
Why?
Patient Selection
1
2014
592
0.090
Why?
Young Adult
2
2017
5717
0.090
Why?
Administration, Oral
1
2010
411
0.080
Why?
Pyrimidines
1
2010
178
0.080
Why?
Drug Administration Schedule
1
2010
567
0.080
Why?
Risk Factors
1
2018
5731
0.080
Why?
Dose-Response Relationship, Drug
1
2010
1745
0.070
Why?
Aged
4
2017
14862
0.060
Why?
Adult
3
2017
21403
0.060
Why?
Visual Acuity
2
2016
236
0.060
Why?
Disease Models, Animal
1
2010
2550
0.050
Why?
Usher Syndromes
1
2022
5
0.050
Why?
Adolescent
4
2017
8912
0.050
Why?
Review Literature as Topic
1
2022
24
0.050
Why?
Retrospective Studies
3
2022
7277
0.050
Why?
Molecular Chaperones
1
2022
81
0.050
Why?
Antigens, Neoplasm
1
2022
132
0.050
Why?
Cytoskeletal Proteins
1
2022
108
0.050
Why?
Treatment Outcome
2
2010
7029
0.050
Why?
ATP-Binding Cassette Transporters
1
2022
120
0.050
Why?
Child
3
2017
6405
0.050
Why?
Cell Cycle Proteins
1
2022
230
0.050
Why?
Membrane Glycoproteins
1
2022
370
0.040
Why?
Subretinal Fluid
1
2016
3
0.040
Why?
Artifacts
1
2017
125
0.030
Why?
Radiotherapy Dosage
1
2016
125
0.030
Why?
Infusions, Intra-Arterial
1
2016
27
0.030
Why?
Vincristine
1
2016
44
0.030
Why?
Etoposide
1
2016
64
0.030
Why?
Carboplatin
1
2016
59
0.030
Why?
Injections, Intravenous
1
2016
215
0.030
Why?
South Carolina
1
2022
2752
0.030
Why?
Microscopy, Acoustic
1
2015
4
0.030
Why?
Biopsy, Needle
1
2015
191
0.030
Why?
Multivariate Analysis
1
2017
1046
0.030
Why?
Circadian Rhythm
1
2014
218
0.030
Why?
Decompression, Surgical
1
2013
55
0.030
Why?
Vision Disorders
1
2013
94
0.030
Why?
Ischemia
1
2013
229
0.020
Why?
Drug Therapy, Combination
1
2013
649
0.020
Why?
Drug and Narcotic Control
1
2010
15
0.020
Why?
Drug Approval
1
2010
50
0.020
Why?
Combined Modality Therapy
1
2013
951
0.020
Why?
Disease Progression
1
2013
1038
0.020
Why?
Aged, 80 and over
1
2017
4848
0.020
Why?
Anti-Bacterial Agents
1
2013
1026
0.020
Why?
Time Factors
1
2013
4655
0.020
Why?
Animals
1
2010
20881
0.010
Why?
Magrath's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (128)
Explore
_
Co-Authors (10)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_